Neuropeptide Y (NPY) intranasal delivery alleviates Machado–Joseph disease
Abstract Machado–Joseph disease (MJD) is the most common dominantly-inherited ataxia worldwide with no effective treatment to prevent, stop or alleviate its progression. Neuropeptide Y (NPY) is a neuroprotective agent widely expressed in the mammalian brain. Our previous work showed that NPY overexp...
Enregistré dans:
Auteurs principaux: | , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5e8895de18654bcbb26bcfb30a822f35 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|